# Canine Lower Respiratory Disease: Diagnostic and Management Strategy


## Key Takeaways

- Thoracic radiography is the initial diagnostic step for suspected lower respiratory disease, with patterns (bronchial, alveolar, interstitial, mixed) guiding differential diagnoses and identifying distribution (e.g., cranioventral for aspiration pneumonia, caudodorsal/diffuse for viral pneumonia).
- Airway sampling via bronchoalveolar lavage (BAL) or tracheal wash is indicated when infection or neoplasia is suspected, or when response to empiric therapy is poor; BAL is preferred for parenchymal disease, yielding cytology and culture to direct therapy.
- Cytologic interpretation of BAL fluid is critical for differentiating bacterial (neutrophilic inflammation, intracellular bacteria), parasitic/allergic (eosinophilic inflammation), or neoplastic causes, while aerobic culture with susceptibility testing confirms bacterial pathogens and guides antimicrobial selection.
- Bronchoscopy offers direct visualization of airway structural lesions (collapse, stenosis, foreign bodies) and allows targeted sampling, but its value lies in guiding interventions and sample collection rather than solely in visual diagnosis, as abnormalities can overlap across disease categories.
- Management strategies are stratified by confirmed disease category, with bacterial pneumonia treated with culture-guided antimicrobials, eosinophilic bronchopneumopathy with glucocorticoids, chronic bronchitis with bronchodilators and immunosuppressants, and fungal pneumonia requiring prolonged systemic antifungal therapy.
- Monitoring involves serial assessment of respiratory rate, effort, auscultatory findings, and repeat thoracic radiographs to confirm resolution, with complications like pleural effusion, bronchiectasis, or pulmonary thromboembolism requiring prompt recognition and specific interventions.

---

This article provides a systematic framework for evaluating and managing lower respiratory disease in dogs. It is written for practicing veterinarians who need a structured approach to the diagnostic reasoning process, from signalment and history through advanced airway sampling and therapeutic decision-making. The focus is on pneumonia, bronchitis, and other conditions affecting the bronchi, bronchioles, and pulmonary parenchyma. Upper respiratory tract disorders, including nasal, pharyngeal, and laryngeal disease, are excluded.

The clinical question this article answers is direct: when a dog presents with cough, tachypnea, or abnormal lung sounds, how does the clinician distinguish among infectious pneumonia, inflammatory airway disease, neoplasia, and non-infectious parenchymal disorders, and what management strategy follows from that distinction? The approach emphasizes the value of cytology and culture over empirical therapy, the role of imaging in characterizing disease distribution, and the importance of recognizing when bronchoscopy adds diagnostic yield.

## At a Glance

| Parameter | Clinical Decision Point |
|---|---|
| Signalment and history | Age, breed, cough duration, exposure history, and vaccination status narrow the differential list before examination |
| Physical examination | Localize disease to lower airways versus parenchyma using auscultation, respiratory pattern, and cough character |
| Thoracic radiographs | Required for all suspected lower respiratory disease, pattern recognition distinguishes bronchial, alveolar, interstitial, and mixed disease |
| Airway sampling | Bronchoalveolar lavage or tracheal wash is indicated when infection or neoplasia is suspected, cytology and culture guide therapy |
| Bronchoscopy | Adds value for structural lesions, foreign bodies, and targeted sampling, not required for every case |
| Acute versus chronic presentation | Acute onset favors infectious or aspiration pneumonia, chronic cough favors bronchitis, collapsing airway, or neoplasia |
| Antimicrobial strategy | Base therapy on cytology and culture when possible, reassess at 48 to 72 hours if no clinical response |
| Monitoring | Repeat imaging and clinical scoring at defined intervals to confirm resolution and detect complications |

## Pathophysiology of Lower Respiratory Disease

The lower respiratory tract comprises the trachea, bronchi, bronchioles, and alveoli. Disease processes affect these compartments in overlapping patterns, and the clinical signs reflect the dominant location of pathology. Bronchial disease produces cough through stimulation of irritant receptors in the airway wall. Parenchymal disease produces tachypnea and hypoxemia through ventilation-perfusion mismatch and reduced compliance. Many conditions, particularly infectious pneumonia, involve both compartments simultaneously.

The defense mechanisms of the lower respiratory tract include the mucociliary escalator, alveolar macrophages, and secretory immunoglobulins. When these defenses are overwhelmed, by either high pathogen burden or impaired clearance, infection establishes in the airways or parenchyma. Aspiration of oropharyngeal contents bypasses normal clearance mechanisms and delivers mixed bacterial populations directly to the lower tract. Viral infections, including canine influenza virus, can damage the respiratory epithelium and predispose to secondary bacterial invasion. Influenza virus infections in dogs have been documented with subtypes H3N8 and H3N2, and these infections should be considered in dogs presenting with acute lower respiratory disease, particularly when there is a history of exposure to other dogs [influenza virus infections in dogs and cats](https://pubmed.ncbi.nlm.nih.gov/19896216/).

## Clinical Presentation and Localization

### History and Signalment

The duration of clinical signs is the first branch point in the diagnostic algorithm. Acute onset of cough, fever, and lethargy in a young dog suggests infectious tracheobronchitis or pneumonia. Chronic cough over weeks to months in a middle-aged or older dog raises suspicion for chronic bronchitis, collapsing trachea, or neoplasia. Breed predispositions matter. Brachycephalic breeds are overrepresented for airway collapse and aspiration. Sporting and working breeds may have higher exposure to kennel environments and respiratory pathogens.

### Physical Examination Findings

Auscultation provides the most useful localizing information. Bronchial sounds that are harsh or increased suggest airway disease. Crackles at the lung periphery suggest alveolar disease and are common in pneumonia. Wheezes indicate narrowed airways, either from bronchoconstriction or intraluminal secretions. Increased respiratory effort with abdominal component indicates significant parenchymal involvement. Fever supports an infectious etiology but is absent in many cases of bronchitis and neoplasia.

The presence of tachypnea is a reliable indicator of lower respiratory involvement. In experimental models of influenza infection, increased respiratory rate correlated with epithelial destruction of small airways, and this sign appeared early in the disease course [influenza-induced tachypnea in cotton rats](https://pubmed.ncbi.nlm.nih.gov/15110527/). In clinical patients, tachypnea out of proportion to the auscultatory findings should prompt thoracic imaging even when lung sounds are unremarkable.

## Diagnostic Imaging

Thoracic radiographs are the initial imaging modality for all dogs with suspected lower respiratory disease. Three-view studies, including both lateral projections and a dorsoventral or ventrodorsal view, are standard. The radiographic pattern guides the differential diagnosis.

Bronchial patterns, characterized by thickened, prominent airway walls, are seen in chronic bronchitis and allergic airway disease. Alveolar patterns, with air bronchograms and lobar consolidation, indicate filling of the airspaces and are typical of pneumonia. Interstitial patterns are less specific and may be seen in early pneumonia, fibrosis, or neoplastic infiltration. Mixed patterns are common, particularly in aspiration pneumonia where bronchial and alveolar changes coexist.

Radiographic distribution also informs the differential. Cranioventral alveolar disease is classic for aspiration pneumonia. Caudodorsal or diffuse alveolar disease is more typical of hematogenous spread or viral pneumonia. A single lobar consolidation in an older dog raises concern for neoplasia, particularly adenocarcinoma. Radiographs are also useful for detecting complications such as pneumothorax, pleural effusion, or bronchiectasis.

## Airway Sampling and Bronchoscopy

### Indications for Sampling

Airway sampling is indicated when infection is suspected, when cytology would change management, or when the radiographic pattern is atypical. Sampling is not required for every dog with a cough. A young dog with acute onset, classic cranioventral alveolar infiltrates, and fever may be treated empirically with close monitoring. Sampling is strongly recommended when the patient is systemically ill, when there has been no response to initial therapy, or when the differential includes neoplasia.

### Bronchoalveolar Lavage

Bronchoalveolar lavage (BAL) is the preferred sampling method for lower respiratory disease because it samples the alveolar and small airway compartments. The procedure requires general anesthesia and a cuffed endotracheal tube. Sterile saline is instilled and aspirated, and the recovered fluid is submitted for cytology and aerobic culture. The cytologic findings distinguish neutrophilic inflammation, which supports bacterial infection, from eosinophilic inflammation, which supports allergic or parasitic disease, and from the presence of neoplastic cells.

Bronchoscopic evaluation adds structural information that lavage alone cannot provide. Airway collapse, stenosis, mucus accumulation, and epithelial irregularities are all visible during bronchoscopy. In feline patients, bronchoscopic abnormalities are common across disease categories, and the presence and number of abnormalities do not reliably differentiate among bronchitis, pneumonia, and neoplasia [bronchoscopic findings in cats with lower respiratory disease](https://pubmed.ncbi.nlm.nih.gov/21314731/). The same principle applies to dogs: bronchoscopy is a sampling and visualization tool, not a diagnostic endpoint. The value lies in targeted collection of samples from the most affected lung lobe and in identification of foreign bodies or masses that require specific intervention.

### Tracheal Wash

Tracheal wash is a less invasive alternative to BAL and can be performed with sedation in many patients. The sample is biased toward the large airways and may miss alveolar disease. For this reason, tracheal wash is appropriate when bronchitis is the primary concern but is less reliable for pneumonia. When the two techniques are compared, BAL provides superior diagnostic yield for parenchymal disease.

## Differential Diagnosis Framework

The differential diagnosis for canine lower respiratory disease is organized by the dominant radiographic pattern and the chronicity of signs. Acute alveolar disease is most often infectious pneumonia, either bacterial, viral, or mixed. Aspiration pneumonia is a common cause in dogs with esophageal disease, laryngeal dysfunction, or a history of vomiting. Chronic bronchial disease is most often chronic bronchitis, which is diagnosed by exclusion of other causes and confirmed by the presence of chronic cough for at least two months with no identifiable underlying cause.

Neoplasia must remain on the differential for any older dog with a chronic cough, particularly when radiographs show a nodular or lobar pattern. Primary lung tumors are more common than metastatic disease in dogs. Inflammatory airway disease, including eosinophilic bronchopneumopathy, produces a bronchointerstitial pattern and responds to immunosuppressive therapy instead of antimicrobials.

Viral etiologies should be considered in outbreak situations or when there is a history of recent boarding or exposure to other dogs. Canine influenza virus infections have been documented in dog populations, and the clinical presentation overlaps with other causes of acute respiratory disease [influenza virus infections in dogs and cats](https://pubmed.ncbi.nlm.nih.gov/19896216/). Diagnostic testing for viral pathogens is most useful when it would change management, such as in a shelter or boarding facility where isolation protocols are needed.

## Diagnostic Algorithm and Decision Points

The diagnostic approach to canine lower respiratory disease follows a staged sequence that balances diagnostic yield against patient risk and cost. The algorithm begins with thoracic imaging and clinicopathologic assessment, proceeds to airway sampling when indicated, and incorporates therapeutic trials only when sampling is declined or deferred.

### Stage 1: Imaging and Clinicopathologic Screening

Thoracic radiography remains the initial imaging modality. Three-view projections (right lateral, left lateral, and ventrodorsal or dorsoventral) allow differentiation of bronchial, interstitial, alveolar, and vascular patterns. Bronchial patterns with parallel linear opacities and ring shadows suggest bronchitis. Alveolar patterns with air bronchograms support pneumonia. A mixed pattern with cranial lung lobe consolidation and tracheobronchial lymphadenopathy raises concern for neoplasia or fungal disease.

Clinicopathologic screening includes a complete blood count, serum biochemistry profile, and urinalysis. Neutrophilia with left shift supports bacterial pneumonia. Eosinophilia may indicate parasitic or hypersensitivity disease. Serum globulin elevation and hypoalbuminemia can accompany chronic fungal infection. Point-of-care lung ultrasound is increasingly used to identify alveolar consolidation, B-lines, and pleural effusion, particularly when radiography is unavailable or the patient is unstable for positioning.

### Stage 2: Decision to Sample Airways

Airway sampling is indicated when imaging confirms lower airway disease, when clinical signs fail to respond to empiric therapy, or when a specific etiologic diagnosis is required. Sampling is contraindicated in patients with severe respiratory distress, uncontrolled hemorrhage risk, or cardiovascular instability. The choice between bronchoalveolar lavage (BAL) and tracheal wash depends on patient size, disease distribution, and available equipment.

| Sampling Method | Indications | Advantages | Limitations |
|---|---|---|---|
| Bronchoalveolar lavage | Diffuse or interstitial disease, suspected pneumonia, research-grade cytology | Samples distal airways and alveoli, higher cellular yield, allows bronchoscopic visualization | Requires general anesthesia, specialised equipment, risk of transient hypoxemia |
| Tracheal wash | Large airway disease, bronchial pattern on radiographs, small patients | Minimal equipment, brief sedation or no anesthesia, lower cost | Samples proximal airways only, higher oropharyngeal contamination risk, lower diagnostic yield for alveolar disease |
| Transthoracic fine needle aspiration | Focal consolidation, mass lesions, peripheral nodules | Direct sampling of focal lesions, no airway contamination | Pneumothorax risk, requires ultrasound or CT guidance, poor yield for diffuse disease |

### Stage 3: Bronchoscopy and Lavage Technique

Bronchoscopy permits direct visualization of the trachea, mainstem bronchi, and segmental airways. Mucosal erythema, excessive mucus, airway collapse, and bronchiectasis are documented systematically. In feline lower respiratory disease, bronchoscopic abnormalities do not reliably differentiate bronchitis, pneumonia, and neoplasia, and cytologic evaluation remains essential for diagnosis. The same principle applies to dogs: visual findings guide sampling location but do not replace lavage cytology and culture.

BAL is performed by wedging the bronchoscope into a subsegmental bronchus and instilling warmed sterile saline. Two to three aliquots of 20 to 25 mL each are typical for a medium-sized dog. The fluid is retrieved by gentle suction and pooled for analysis. The first aliquot is more representative of bronchial contents and is suitable for culture. Subsequent aliquots better reflect alveolar populations and are preferred for cytology. Sample handling is critical. A portion is placed in EDTA for cytology, a portion in sterile containers for aerobic and Mycoplasma culture, and additional aliquots are reserved for molecular testing if fungal or viral disease is suspected.

### Stage 4: Cytologic Interpretation

Cytologic evaluation of BAL fluid includes total nucleated cell count, differential count, and assessment of cellular morphology. Normal canine BAL fluid contains predominantly alveolar macrophages with fewer lymphocytes and neutrophils. Neutrophilic inflammation supports bacterial or fungal pneumonia. Eosinophilic inflammation suggests parasitic, hypersensitivity, or eosinophilic bronchopneumopathy. Lymphocytic or mixed inflammation occurs with chronic bronchitis and neoplasia.

Intracellular bacteria within neutrophils are strong evidence of bacterial pneumonia. Extracellular bacteria may represent contamination and should be interpreted cautiously. The presence of goblet cells, ciliated epithelial cells, and mucus supports airway disease. Neoplastic cells, when present, confirm malignancy, but a negative cytology does not exclude neoplasia.

### Stage 5: Culture and Molecular Testing

Aerobic bacterial culture with antimicrobial susceptibility testing is performed on all BAL samples from dogs with suspected pneumonia. Quantitative culture thresholds help distinguish true infection from oropharyngeal contamination. Growth of a single organizm at high density with matching cytologic inflammation is diagnostically significant. Mixed growth of multiple organizms at low density more likely reflects contamination.

Mycoplasma culture requires specialised media and should be requested specifically when cytology shows neutrophilic inflammation without visible bacteria. Molecular testing by PCR is available for Mycoplasma, Bordetella bronchiseptica, influenza virus, and fungal organizms. Influenza virus infection should be considered in dogs with acute onset of lower respiratory disease, particularly with a history of exposure to other dogs or endemic regions. The clinical relevance of viral detection depends on correlation with cytology and serology, as subclinical infection occurs.

## Treatment Decision Framework

Treatment selection follows the diagnostic findings and is stratified by disease category. The framework below assumes that sampling has been performed and cytologic and culture results are available.

| Disease Category | Primary Therapy | Adjunctive Therapy | Monitoring Parameters | Duration |
|---|---|---|---|---|
| Bacterial pneumonia | Antimicrobial selected by culture and susceptibility | Nebulisation and coupage, hydration support | Respiratory rate and effort, fever, appetite, thoracic radiographs | 3 to 6 weeks, recheck radiographs 7 to 14 days after clinical resolution |
| Eosinophilic bronchopneumopathy | Glucocorticoids | Bronchodilators if cough is severe | Cough frequency, exercise tolerance, eosinophil count | Taper over 8 to 12 weeks, then lowest effective dose |
| Chronic bronchitis | Glucocorticoids, bronchodilators | Weight management, environmental modification | Cough frequency, respiratory effort, quality of life | Long-term, adjust to lowest effective dose |
| Fungal pneumonia | Systemic antifungal therapy | Supportive care, oxygen if hypoxemic | Serial antigen titers, thoracic radiographs, hepatic enzyme monitoring | 6 to 12 months or until resolution |

Antimicrobial selection for bacterial pneumonia should follow culture and susceptibility results. Empiric therapy is justified only when sampling is declined or the patient is unstable, and it should be reassessed once culture results are available. The current formulary and label references must be consulted for doses, as antimicrobial choices vary by region and resistance patterns. Antimicrobial resistance in Pasteurella multocida, a common respiratory pathogen across species, remains low for most drug classes in some livestock populations, but companion animal isolates may differ, and susceptibility testing is the only reliable guide.

## Monitoring and Reassessment

Clinical monitoring focuses on respiratory rate and effort, cough frequency, appetite, and temperature. Improvement is expected within 48 to 72 hours of appropriate antimicrobial therapy for bacterial pneumonia. Lack of response within this window prompts reassessment of the diagnosis, culture results, and drug penetration.

Thoracic radiographs are repeated 7 to 14 days after clinical resolution to document radiographic clearing. Radiographic resolution lags clinical improvement by days to weeks. Persistent radiographic abnormalities beyond 6 weeks warrant further investigation, including repeat sampling or advanced imaging.

Serial monitoring of inflammatory markers such as serum C-reactive protein or fibrinogen can support treatment response but is not a substitute for clinical and radiographic assessment. Pulse oximetry and arterial blood gas analysis are indicated in patients with moderate to severe respiratory compromise. Persistent hypoxemia despite therapy warrants oxygen supplementation and reassessment of the treatment plan.

## Documentation and Communication

The medical record should document the indication for sampling, the technique used, the volume of fluid instilled and retrieved, the cytologic findings, and the culture results. Bronchoscopic findings are recorded using a standardized description of each airway segment. Photographic or video documentation is valuable for serial comparison.

Client communication addresses the expected timeline for response, the duration of therapy, and the signs that warrant re-evaluation. Owners should understand that chronic bronchitis and eosinophilic bronchopneumopathy require long-term management instead of cure. The prognosis for bacterial pneumonia is good with appropriate antimicrobial therapy, while fungal pneumonia carries a more guarded prognosis and requires prolonged treatment.

## Recognized Complications and Early Detection

Lower respiratory disease in dogs can progress through several recognizable failure modes. The most consequential is progression from focal pneumonia to diffuse alveolar disease with impaired gas exchange. Detect this early by tracking respiratory rate at rest, pulse oximetry trends, and serial thoracic radiographs. A rising resting respiratory rate, typically above 40 breaths per minute in an adult dog, often precedes audible changes on auscultation and should prompt reassessment instead of continued observation.

Pleural effusion can complicate pneumonia, particularly with abscessation or neoplasia. Radiographic signs include blunting of the costophrenic angles, retraction of lung lobes from the thoracic wall, and a fissure sign. Ultrasonography is more sensitive than radiography for small volumes and should be performed when effusion is suspected. Thoracocentesis for cytology and culture should follow promptly.

Bronchiectasis is a structural complication of chronic or recurrent airway inflammation. It is detected radiographically as thickened, dilated airways that fail to taper normally, and is confirmed bronchoscopically. Once established, bronchiectasis is irreversible and predisposes to recurrent infection through impaired mucociliary clearance. Early recognition matters because management shifts from cure to suppression.

Pulmonary thromboembolism is an under-recognized complication, particularly in dogs with protein-losing nephropathy, hyperadrenocorticism, or prolonged recumbency. Acute onset of tachypnea, dyspnea, or collapse with minimal radiographic change should raise suspicion. Advanced imaging, including CT angiography, is required for confirmation.

## Common Errors and Corrective Actions

| Observation | Likely Cause | Discriminating Check |
|---|---|---|
| Radiographic interstitial pattern interpreted as pneumonia | Normal aging change, obesity, or expiratory phase imaging | Repeat radiographs in inspiratory phase, compare with prior studies |
| Negative culture from a dog with suspected bacterial pneumonia | Prior antimicrobial therapy, inadequate sample volume, or delayed plating | Review treatment history, repeat sampling after antimicrobial withdrawal where feasible |
| BAL cytology dominated by oropharyngeal contamination | Sampling technique error, excessive suction, or inadequate wedge position | Evaluate for squamous epithelial cells and check sampling records |
| Persistent cough after apparent resolution of pneumonia | Residual airway inflammation, bronchiectasis, or undiagnosed collapse | Repeat imaging, consider bronchoscopy for structural assessment |
| Poor response to empirical antimicrobials | Viral or fungal etiology, resistant bacteria, or non-infectious disease | Broaden diagnostic testing, including culture and cytology review |

Less experienced clinicians commonly over-interpret a single radiographic view. A right lateral, left lateral, and ventrodorsal series is required to avoid missing lesions hidden by the cardiac silhouette or diaphragm. Another frequent error is sampling airways after starting antimicrobials, which reduces culture yield and complicates cytologic interpretation. When antimicrobial therapy is clinically urgent, collect airway samples before the first dose.

Clinicians also tend to under-use bronchoscopy in dogs with chronic cough and normal radiographs. Bronchoscopic evaluation can identify airway collapse, mucus accumulation, and mucosal abnormalities that are invisible on imaging, and it permits targeted sampling of affected lung lobes. The procedure is well tolerated in most dogs and should be considered earlier in the diagnostic pathway instead of as a last resort.

## Limitations of Current Evidence

The evidence base for canine lower respiratory disease is uneven. Much of the bronchoscopic literature derives from feline studies, and extrapolation to dogs requires caution. One institutional review of bronchoscopic findings in cats with lower respiratory disease found that endobronchial abnormalities were common across bronchitis, pneumonia, and neoplasia, with no single feature reliably distinguishing among them. Similar limitations likely apply in dogs, meaning cytology and culture remain essential for diagnosis.

Antimicrobial resistance data for respiratory pathogens in dogs are sparse. Studies in other species, such as porcine Pasteurella multocida isolates, show that resistance patterns vary by region and antimicrobial class, and that dominant strains can spread across farms and hosts. Comparable surveillance data for canine respiratory isolates are lacking, so empirical antimicrobial choices should be guided by local susceptibility patterns where available.

Influenza virus infections in dogs are documented, including H3N8 and H3N2 subtypes, and should be considered in dogs with acute onset of lower respiratory signs, particularly with a history of exposure to other dogs. The clinical significance of other viral pathogens, including canine respiratory coronavirus and pneumovirus, remains less well defined, and expert opinion differs on how aggressively to pursue viral diagnostics in individual cases.

## Referral and Escalation Criteria

Referral to a specialist should be considered when a dog fails to improve despite appropriate therapy, when bronchoscopy or advanced imaging is required but unavailable, or when the suspected diagnosis falls outside the comfort of the primary clinician. Specific indications include suspected pulmonary neoplasia requiring biopsy, suspected foreign body, severe or recurrent pneumonia, and suspected pulmonary hypertension or thromboembolism.

Specialist consultation is also appropriate when cytologic interpretation is ambiguous, when culture results do not match clinical expectations, or when a dog requires mechanical ventilation. Veterinary diagnostic laboratories can assist with sample handling, specialized culture techniques, and molecular testing, and early contact with the laboratory before sampling is advisable.

Regulatory reporting obligations vary by jurisdiction. Influenza virus infections in dogs may be reportable in some regions, and any suspicion of a notifiable disease should be checked against current local requirements. The World Organization for Animal Health maintains international standards for disease surveillance and reporting, and veterinarians should be familiar with the obligations that apply in their practice location. When in doubt, contact the relevant animal health authority before acting.

## Frequently Asked Questions

### How Should I Proceed When Bronchoscopy and BAL Are Not Available?

When bronchoscopy is unavailable, a tracheal wash remains a practical alternative for airway sampling in dogs with suspected lower respiratory disease. Perform the wash before starting antimicrobial therapy whenever possible. If the patient is unstable for sampling, begin empirical treatment based on imaging findings and cytology from any available sample. In referral settings, [ACVIM consensus statements](https://www.acvim.org/Animal-Owners/Animal-Education/Consensus-Statements) provide structured guidance on diagnostic thresholds and sample handling when advanced equipment is limited. A negative tracheal wash does not exclude parenchymal disease, so clinical response and serial imaging should guide further decisions. If the dog deteriorates despite appropriate therapy, referral for bronchoscopy is indicated even if initial sampling was performed.

### What Are the Minimum Cytologic Criteria for Confirming Bacterial Pneumonia?

Bacterial pneumonia is supported by septic neutrophilic inflammation, intracellular bacteria, or both in a good-quality airway sample. Degenerate neutrophils with visible phagocytosed cocci or rods are the most reliable cytologic findings. Extracellular bacteria alone are less specific because oropharyngeal contamination can occur during sampling. A mixed population of degenerate and nondegenerate neutrophils with macrophages suggests chronic or resolving infection. If cytology shows predominantly eosinophilic inflammation, consider parasitic or hypersensitivity disorders instead of bacterial disease. Culture results should be interpreted alongside cytology, since a positive culture without corresponding cytologic inflammation may represent contamination. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) reviews sample quality criteria and interpretation standards for airway cytology.

### How Do I Manage a Dog With Suspected Lower Respiratory Disease When the Owner Declines Advanced Diagnostics?

When advanced diagnostics are declined, establish a therapeutic trial with clear decision points. Choose an antimicrobial with good pulmonary penetration and activity against common canine respiratory pathogens, and document the expected response interval. Reassess the dog at 48 to 72 hours for clinical improvement, and again at 7 to 10 days for imaging or clinical resolution. If the dog fails to improve within the expected window, revisit the diagnostic plan instead of simply rotating antimicrobials. Owners should understand that a therapeutic trial can delay diagnosis of neoplasia or fungal disease, and that persistent cough or tachypnea after treatment warrants further investigation. Document the owner's decision and the rationale for the trial in the medical record.

### What Monitoring Parameters Are Most Useful During Treatment of Bacterial Pneumonia?

Serial assessment of respiratory rate and effort, mucous membrane color, and auscultatory findings provides the most accessible monitoring during treatment. Temperature and appetite typically improve within 48 to 72 hours of effective therapy, while cough may persist for 1 to 3 weeks despite radiographic improvement. Repeat thoracic radiographs are recommended 2 to 4 weeks after clinical resolution to confirm clearing of pulmonary infiltrates, since radiographic changes lag behind clinical improvement. Persistent tachypnea or hypoxemia beyond 72 hours of appropriate therapy warrants reassessment of the diagnosis, including consideration of resistant organizms, foreign body, or noninfectious disease. The [AVMA practice resources](https://www.avma.org/resources-tools) include guidance on antimicrobial stewardship and monitoring during respiratory disease treatment.

### How Should I Document Antimicrobial Choices and Treatment Response in the Medical Record?

Record the indication for antimicrobial therapy, the drug selected, the dose and duration, and the evidence supporting the choice, such as cytology, culture, or imaging findings. Note the date of treatment initiation and the planned reassessment point. At each recheck, document respiratory rate, effort, auscultatory findings, and owner-reported cough frequency. If antimicrobials are changed, record the reason, including culture results, lack of response, or adverse effects. This documentation supports antimicrobial stewardship reviews and provides a clear timeline if the case is referred. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) emphasize responsible antimicrobial use in companion animals, and a complete record demonstrates compliance with that expectation.

### When Should I Suspect a Noninfectious Cause Despite Positive Airway Cultures?

A positive culture does not confirm infection if cytology lacks evidence of inflammation. Oropharyngeal contamination, recent antimicrobial therapy, and sample handling errors can produce false-positive cultures. Suspect a noninfectious process when the dog has chronic cough, minimal systemic signs, and imaging shows bronchointerstitial or alveolar patterns that fail to respond to appropriate antimicrobials. Eosinophilic bronchitis, neoplasia, and aspiration pneumonitis can all present with secondary bacterial colonization. If the dog improves clinically but radiographs remain abnormal, consider follow-up imaging before extending antimicrobial therapy. When response is incomplete, bronchoscopy with repeat sampling and biopsy is indicated to distinguish persistent infection from underlying structural or neoplastic disease.

## Related Clinical & Scientific Guides

* [Feline Hepatic Lipidosis: Nutritional and Medical Management](/knowledge/veterinary-medicine/clinical-internal-medicine/feline-hepatic-lipidosis-nutritional-medical-management)
* [Canine Respiratory Infection: Diagnostic Approach and Treatment](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-respiratory-infection-diagnostic-approach-treatment)
* [Canine Respiratory Virus: Diagnostic and Management Considerations](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-respiratory-virus-diagnostic-management-considerations)


## References and Further Reading

- [Bronchoscopic findings in 48 cats with spontaneous lower respiratory tract disease (2002-2009).](https://pubmed.ncbi.nlm.nih.gov/21314731/). 2011.
- [Influenza virus infections in dogs and cats.](https://pubmed.ncbi.nlm.nih.gov/19896216/). 2010.
- [Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans.](https://pubmed.ncbi.nlm.nih.gov/34452415/). 2021.
- [Bovine respiratory syncytial virus infections in young dairy cattle: clinical and hematological findings.](https://pubmed.ncbi.nlm.nih.gov/6702077/). 1984.
- [Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.](https://pubmed.ncbi.nlm.nih.gov/15110527/). 2004.
- [Antimicrobial Resistance of and Genomic Insights into Pasteurella multocida Strains Isolated from Australian Pigs.](https://pubmed.ncbi.nlm.nih.gov/36651773/). 2023.
- [ACVIM Consensus Statements](https://www.acvim.org/Animal-Owners/Animal-Education/Consensus-Statements). Journal of Veterinary Internal Medicine.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.

## Related Articles

- [Canine Respiratory Virus: Diagnostic and Management Considerations](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-respiratory-virus-diagnostic-management-considerations)
- [Canine and Feline Hepatobiliary Disease: Diagnostic Imaging and Sampling](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-feline-hepatobiliary-disease-imaging-sampling)
- [Canine Immune-Mediated Skin Disease: Diagnostic and Management Approach](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-immune-mediated-skin-disease-diagnostic-management-approach)
- [Canine Upper Respiratory Disease: Differential Diagnosis and Management](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-upper-respiratory-disease-differential-diagnosis-management)
- [Canine Acute Respiratory Distress Syndrome: Diagnostic Criteria and Management](/knowledge/veterinary-medicine/clinical-internal-medicine/canine-acute-respiratory-distress-syndrome-diagnostic-criteria-management)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.